HomeRVMD • NASDAQ
add
Revolution Medicines Inc
Previous close
$46.77
Day range
$46.13 - $47.62
Year range
$15.44 - $48.61
Market cap
7.67B USD
Avg Volume
1.89M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 22.84M | 72.70% |
Net income | -116.00M | -70.35% |
Net profit margin | — | — |
Earnings per share | -0.70 | 2.78% |
EBITDA | -139.35M | -88.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.70B | 87.24% |
Total assets | 1.91B | 77.81% |
Total liabilities | 182.90M | 51.12% |
Total equity | 1.73B | — |
Shares outstanding | 164.99M | — |
Price to book | 4.47 | — |
Return on assets | -17.74% | — |
Return on capital | -18.89% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -116.00M | -70.35% |
Cash from operations | -160.56M | -157.34% |
Cash from investing | -247.97M | -6,305.36% |
Cash from financing | 810.00K | -99.75% |
Net change in cash | -407.72M | -253.39% |
Free cash flow | -122.50M | -200.92% |
About
Founded
2014
Headquarters
Website
Employees
411